Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Da Huang total anthraquinone capsule
- Development stage
- Unknown
- Lead developer
- Jiangxi Baishen Pharmaceutical
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Da Huang total anthraquinone capsule is a botanical pharmaceutical product developed by Jiangxi Changnuo Pharmaceutical Co., Ltd. It is composed of the total anthraquinone fraction extracted from the Chinese medicinal herb Da Huang (Rhubarb, *Rheum palmatum* L. or *Rheum officinale* Baill.), which includes active compounds such as emodin, rhein, chrysophanol, physcion, and aloe-emodin. The drug is primarily indicated for the treatment of jaundice in patients with chronic hepatitis B. Its therapeutic effects are attributed to its ability to promote bile secretion and excretion (choleretic effect), reduce serum bilirubin levels, and exert anti-inflammatory and hepatoprotective activities. It has been evaluated in Phase IV clinical trials in China to further establish its safety and efficacy in clinical practice.
- Brand names
- Kehuang Lidan
- Other names
- Rhubarb total anthraquinone capsulesDahuang Zong'enkun Jiaonang
02
Targets
CK2 (Casein kinase II subunit alpha)
Beyond the preview
Go deeper on Da Huang total anthraquinone capsule.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Da Huang total anthraquinone capsule.